Therapies such as anti-janus kinase, anti-interleukin, and anti-tumor necrosis factor are at the forefront, reflecting a new era of drug therapy. Increasing Public Awareness: Growing awareness of ...

Researchers report results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors ...

Discover how nicotinamide riboside reduces airway inflammation in COPD patients by lowering IL-8 levels and enhancing ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to ...

In a new study of mouse cells, scientists found that both the biochemical and mechanical effects of exercise may help injured ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell ...

FDA Project Team supports the company's proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment schedule, and primary endpoint Final Protocol submission ...

IMUNON (IMNN) announced the outcome of its recent End-of-Phase 2 in-person meeting with the U.S. Food and Drug Administration, FDA, supporting ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study explains how a type of cancer cell death can actually make ...

A daily dose of vitamin B3 reduced inflammation in the lungs of patients with COPD, Danish researchers report. "T ...

Protagonist' or the 'Company') today announced the selection of PN-881, a potential best-in-class oral peptide interleukin-17 (IL-17) antagonist ... including under the heading 'Risk Factors' ...